Results 271 to 280 of about 2,138,197 (387)

Mapping CSC‐Mediated Ovarian Cancer Chemoresistance via CXCR4‐PET to Guide Precision Cisplatin Re‐Sensitization Therapy

Advanced Science, EarlyView.
CXCR4 functions as a potential cancer stem cell‐associated marker linked to chemoresistance in ovarian cancer, and an inhibitor of CXCR4, AMD3100, can enhance the cytotoxic response to cisplatin. Based on these findings, [68Ga]Ga‐Pentixafor positron emission tomography enables selective visualization of CXCR4‐high ovarian cancer, while AMD3100 combined
Lixia Feng, Simei Zhao, Zheng Wei, Wenwen Wang, Feiquan Ying, Lin Huang, Mengna Zhu, Mengqing Chen, Qiang Yang, Si Sun, Dawei Jiang, Lingling Gao, Jing Cai   +12 more
wiley   +1 more source

Alternative splicing patterns in genetic subtypes of diffuse large B-cell lymphoma. [PDF]

BMC Cancer
An S, Hong J, Shin DY, Byun JM, Koh Y, Yoon SS.   +5 more
europepmc   +1 more source

Data from A Phase I Clinical Trial Adding OX40 Agonism to <i>In Situ</i> Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human Studies

Tanaya Shree, Debra K. Czerwinski, Sarah Haebe, Anuja Sathe, Susan M. Grimes, Brock A. Martin, Michael G. Ozawa, Richard T. Hoppe, Hanlee P. Ji, Ronald Levy   +9 more
openalex   +1 more source

Pembrolizumab as salvage treatment for T‐cell/histiocyte‐rich and Epstein–Barr virus‐positive large B‐cell lymphoma [PDF]

Alberto Schena, Francesca Maria Quaglia, A. Parisi, I. Ferrarini, Alessia Moioli, Fabrizio Tagliavini, Andrea Bernardelli, Carlo Visco   +7 more
openalex   +1 more source

Antibody‐Empowered Nanomedicine for Precise Biomedical Applications

Advanced Science, EarlyView.
This review explores strategies for functionalizing nanoparticles with antibodies to construct antibody‐empowered nanomedicine. It discusses the classification of these nanomedicines based on antibody structure, with a specific focus on their biomedical applications in diagnostics, bioimaging, and therapeutics for various diseases.
Chen Chen, Xinglin Chen, Zhenhao Gao, Meng Sun, Yaozong Yu, Fang Lv, Qiujun Wang, Jinfeng Zhang   +7 more
wiley   +1 more source

Pheochromocytoma and Diffuse Large B-Cell Lymphoma in the Ipsilateral Adrenal Gland: A Case Report. [PDF]

IJU Case Rep
Maekawa K, Sakatani T, Kita Y, Masui K, Goto T, Teramoto Y, Hosokai T, Yamauchi I, Koyasu S, Kobayashi T.   +9 more
europepmc   +1 more source

KMT2C Loss Promotes NF2‐Wildtype Meningioma Progression and Ferroptosis Sensitivity via Epigenetic Repression of Hippo Signaling

Advanced Science, EarlyView.
In NF2–wild‐type meningiomas, loss of the epigenetic regulator KMT2C suppresses NF2 transcription and inactivates Hippo signaling, driving tumor progression and increasing ferroptosis sensitivity. Restoration of histone acetylation reverses these effects and inhibits tumor growth, identifying KMT2C as a key regulator linking epigenetic control, NF2 ...
Liuchao Zhang, Yangfan Ye, Wei Gu, Xinyue Wang, Nuo Chen, Qixin He, Lei Xu, Pengzhan Zhao, Guoqiang Fu, Guangyao Yuan, Wenqian Shi, Honglu Chao, Yiming Tu, Jing Ji   +13 more
wiley   +1 more source

Computational modelling of aggressive B-cell lymphoma. [PDF]

Biochem Soc Trans
Jayawant ES, Vareli A, Pepper A, Pepper C, Simoes F, Mitchell S.   +5 more
europepmc   +1 more source

Fever and arthralgia as the initial symptoms of primary bone marrow diffuse large B-cell lymphoma: A case report

, 2016
Saisai Ren, Yanling Tao, Lu Jia, Panpan Cheng, Jilei Zhang, Hao Zhang   +5 more
openalex   +2 more sources

Genetics of diffuse large B-cell lymphoma.

Blood, 2018
L. Pasqualucci, R. Dalla-Favera
semanticscholar   +1 more source